Last reviewed · How we verify

Automatic system guided treatment

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health · FDA-approved active Small molecule

An automated clinical decision support system that guides treatment selection and management based on patient data and clinical protocols.

An automated clinical decision support system that guides treatment selection and management based on patient data and clinical protocols. Used for Clinical treatment guidance and optimization across multiple therapeutic areas.

At a glance

Generic nameAutomatic system guided treatment
SponsorFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
ModalitySmall molecule
PhaseFDA-approved

Mechanism of action

This is a software-based system rather than a pharmacological drug, designed to provide real-time treatment recommendations to clinicians. It integrates patient information, diagnostic data, and evidence-based guidelines to optimize therapeutic decision-making and improve clinical outcomes through systematic guidance.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: